Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction

Annals of Allergy, Asthma and Immunology

Volumn 76, Issue 1, 1996, Pages 57-60

  Schaanning, Jan ^a   Vilsvik, Jan ^a   Henriksen, Anne H ^a   Bratten, Gry ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b Glaxo Wellcome of Norway   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

SALMETEROL;

ARTICLE; BRONCHODILATATION; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EXERCISE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030025069     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63407-2     Document Type: Article

References (13)

1. Godfrey S. Exercise-induced asthma. Arch Dis Child 1983;58:1-2.
2. Wooley M, Anderson SD, Quigley BM. Duration of protective effect of terbutaline sulphate and cromolyn sodium alone and in combination on exercise asthma. Chest 1990;97:39-45.
3. Vilsvik J, Schaanning J. A comparative study of the effect of three doses of nedocromil sodium and placebo given by pressurized aerosol to asthmatics with exercise-induced bronchoconstriction. Ann Allergy 1988;61: 367-70.
4. Vilsvik J, Schaanning J, Ståhl E, Holthe S. Comparison between Bricanyl turbuhaler and Ventolin metered dose inhaler in the treatment of exercise-induced asthma in adults. Ann Allergy 1991;67:315-8.
5. Higgs CMB, Lazlo G. The duration of protection from exercise-induced asthma by inhaled salbutamol, and a comparison with inhaled reproterol. Brit J Dis Chest 1983;77:262-9.
6. 2-adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 1988;43:674-8.
7. Green CP, Price JF. Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Child 1992;67:1014-7.
8. 2-agonist. Eur Respir Rev 1993;3:14, 391-5.
9. Newnham DM, Ingram CG, Earnshaw J, et al. Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma. J Respir Med 1993;87:439-44.
10. Twentyman OP, Finnerty JP, Harris A, et al. Protection against allergen-induced asthma by salmeterol. Lancet 1990;336:1338-42.
11. . Pedersen B, Dahl R, Larsen BB, Venge P. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinopnil cationic protein, and serum eosinopnil protein X. Allergy 1993;48:377-82.
12. Gulsvik A. Spirometry, methods and reference values in the 1980's. J Norwegian Med Assoc 1985;105:2240-1.
13. Ramage L. Lipworth BJ, Ingram CG, et al. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1994;88:363-8